** Shares of Inhalerx surge as much as 127.3% to A$0.050, their biggest pct gain since March 2020

** Medical device maker to get up to A$38.5 mln ($25.81 mln) in funds from Clendon Biotech Capital to cover clinical trial costs

** Stock hits its highest level since late March

** Around 3.7 mln shares change hands, 72.3x the 30-day avg

** Stock up 34.5% YTD, including current session, as at 0140 GMT

($1 = 1.4916 Australian dollars)

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com;))